TEZSPIRE is indicated for the add-on maintenance treatment of adult and pediatric patients aged
12 years and
older with severe asthma.
TEZSPIRE is not
indicated
for the relief of acute bronchospasm or status asthmaticus.
Find your location below to begin editing or removing.
No results. We are working to build network. Please try search different location.
If you wish to add location, please submit here
Need to add location?
*Based on Q2'23-Q3'23 vs Q4'22-Q1'23 NBRx growth rate in major global markets.
SEE MORE
Please see Full Prescribing Information including Patient Information and Instructions for Use.
You may report side effects related to AstraZeneca products by clicking here.